Skip to main content
. 2020 Jul 12;11(1):100–111. doi: 10.1016/j.apsb.2020.07.004

Figure 7.

Figure 7

Schematic of the mechanism underlying the YD inhibition of hepatic fibrosis development. YD could decrease miR-155 expression, which is responsible for the upregulation of CASP12, leading to the decreased secretion of inflammatory cytokines via inactivation of NF-κB pathway, and finally inhibit the development of fibrosis. Green arrows indicate the facilitation of this process, whereas red blocks represent the inhibition of this process.